Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Senseonics Holdings (SENS)

Senseonics Holdings (SENS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 176,785
  • Shares Outstanding, K 530,886
  • Annual Sales, $ 22,390 K
  • Annual Income, $ -60,390 K
  • 60-Month Beta 0.79
  • Price/Sales 8.02
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade SENS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.13
  • Most Recent Earnings $-0.03 on 08/08/24
  • Next Earnings Date 11/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 107.64% ( -31.56%)
  • Historical Volatility 83.72%
  • IV Percentile 40%
  • IV Rank 20.43%
  • IV High 516.52% on 11/29/23
  • IV Low 2.66% on 01/16/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 277
  • Volume Avg (30-Day) 768
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 52,169
  • Open Int (30-Day) 48,631

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.03
  • Number of Estimates 4
  • High Estimate -0.03
  • Low Estimate -0.04
  • Prior Year -0.04
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3200 +6.81%
on 09/06/24
0.5680 -39.82%
on 09/17/24
-0.0292 (-7.87%)
since 09/04/24
3-Month
0.3200 +6.81%
on 09/06/24
0.5680 -39.82%
on 09/17/24
-0.0493 (-12.61%)
since 07/03/24
52-Week
0.3200 +6.81%
on 09/06/24
0.7500 -54.43%
on 02/26/24
-0.2127 (-38.36%)
since 10/04/23

Most Recent Stories

More News
Ascensia Diabetes Care and Senseonics Announce 'The CGM for Real Life' Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes

/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, and Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company...

SENS : 0.3430 (+3.00%)
ASCENSIA DIABETES CARE EXPANDS PAYMENT ASSISTANCE AND SIMPLE SAVINGS PROGRAM FOR EVERSENSE E3 CGM SYSTEM

/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring (BGM) System portfolio and exclusive...

SENS : 0.3430 (+3.00%)
Senseonics Holdings, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 9, 2023, at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people...

SENS : 0.3430 (+3.00%)
ASCENSIA DIABETES CARE MARKS ONE-YEAR ANNIVERSARY OF US EVERSENSE E3 CGM LAUNCH WITH COMMERCIAL UPDATE AND INNOVATION OUTLOOK

/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring (BGM) system portfolio and exclusive...

SENS : 0.3430 (+3.00%)
Senseonics Announces the First Pediatric Study Participant Insertions in the ENHANCE Clinical Trial

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people...

SENS : 0.3430 (+3.00%)
Senseonics Announces Equity Grants To Employees Under Inducement Plan

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) system for people...

SENS : 0.3430 (+3.00%)
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people...

SENS : 0.3430 (+3.00%)
Senseonics Holdings, Inc. and PHC Holdings Corporation To Host Joint Eversense CGM Virtual Analyst and Investor Event on March 15, 2023

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people...

SENS : 0.3430 (+3.00%)
Senseonics Announces Equity Grants To Employees Under Inducement Plan

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people...

SENS : 0.3430 (+3.00%)
Energous Collaborates with Sensirion to Develop Wirelessly Powered CO2 Sensors

Energous Corporation (NASDAQ: WATT), a leading developer of RF-based charging for wireless power networks, and Sensirion (SIX: SENS), provider of industry leading CO2 sensor products, today announced...

WATT : 0.5600 (+2.75%)
SENS : 0.3430 (+3.00%)

Business Summary

Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.

See More

Key Turning Points

3rd Resistance Point 0.3445
2nd Resistance Point 0.3403
1st Resistance Point 0.3366
Last Price 0.3430
1st Support Level 0.3287
2nd Support Level 0.3245
3rd Support Level 0.3208

See More

52-Week High 0.7500
Fibonacci 61.8% 0.5857
Fibonacci 50% 0.5350
Fibonacci 38.2% 0.4843
Last Price 0.3430
52-Week Low 0.3200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar